Hepatopulmonary syndrome and portopulmonary hypertension

Swiss Medical Weekly

Volumn 133, Issue 11-12, 2003, Pages 163-169

  Naeije, Robert ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b Erasme Campus   (Belgium)

Author keywords

Hepatopulmonary syndrome; Hypoxaemia; Liver cirrhosis; Portal hypertension; Pulmonary hypertension

Indexed keywords

ANGIOGENIC FACTOR; PROSTACYCLIN; VASOACTIVE AGENT;

ARTERIAL OXYGEN TENSION; CLUBBING FINGERS; CYANOSIS; DRUG RESPONSE; DYSPNEA; FATIGUE; HEPATOPULMONARY SYNDROME; HISTOPATHOLOGY; HUMAN; HYPOXEMIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MORTALITY; PATHOGENESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PULMONARY HYPERTENSION; REVIEW; SYMPTOMATOLOGY; VASODILATATION;

EID: 0037676212     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Naeije R, Mélot C, Hallemans R, Mols P, Lejeune P. Pulmonary hemodynamics in liver cirrhosis. Semin Respir Med 1985;7: 164-71.
2. Hallemans R, Naeije R, Mols P, Mélot C, Reding P. Treatment of portal hypertension with isosorbide dinitrate, alone or in combination with vasopressin. Crit Care Med 1983;11:536-40.
3. Naeije R, Hallemans R, Mols P, Mélot C, Reding P. Effects of vasopressin and somatostatin on hemodynamics and blood gases in patients with liver cirrhosis. Crit Care Med 1982;10:578-82.
4. Mols P, Hallemans R, Van Kuyk M, Mélot C, Lejeune P, Ham H, et al. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension. Ann Surg 1984;199:176-81.
5. Naeije R, Hallemans R, Mols P, Mélot C. Hypoxic pulmonary vasoconstriction and liver cirrhosis. Chest 1981;80:570-4.
6. Snell AM. The effects of chronic disease of the liver on the composition and physicochemical properties of blood: changes in the serum proteins, reduction in the oxygen saturation of the arterial blood. Ann Intern Med 1935;9:690-711.
7. Heineman HO, Emirgil C, Mijnssen JP. Hyperventilation and arterial hypoxemia in cirrhosis of the liver. Am J Med 1960;28: 239-46.
8. Rodman T, Sobel M, Close HP. Arterial oxygen saturation and the ventilation-perfusion defect of Laennec's cirrhosis. N Engl J Med 1960;263:73-7.
9. Keys A, Snell AM. Respiratory properties of the arterial blood in normal men and in patients with disease of the liver: position of the oxygen dissociation curve. J Clin Invest 1938;17:59-67.
10. Caldwell PRB, Fritts HW, Cournand A. Oxyhemoglobin dissociation curve in liver cirrhosis. J Appl Physiol 1965;20: 316-20.
11. Zimmon DS. Oxyhemoglobin dissociation in patients with hepatic encephalopathy. Gastroenterology 1967;52:747-54.
12. Astrup J, Rorth M. Oxygen affinity of hemoglobin and red cell 2,3-diphosphoglucerate in hepatic cirrhosis. Scand J Clin Lab Invest 1973;31:311-5.
13. Karetsky MS, Mithoefer JC. The cause of hyperventilation and arterial hypoxia in patients with cirrhosis of the liver. Am J Med Sci 1967;254:797-804.
14. Abelman WH, Kramer GE, Verstraeten JM, Gravallese Ma, Mc Neely WF. Cirrhosis of the liver and decreased arterial oxygen saturation. Arch Intern Med 1961;108:102-8.
15. Massumi RA, Rios JC, Ticktin HE. Hemodynamic abnormalities and venous admixture in portal cirrhosis. Am J Med Sci 1965;250:275-83.
16. Williams MH. Hypoxemia due to venous admixture in cirrhosis of the liver. J Appl Physiol 1960;15:253-4.
17. Bashour FA, Cochran P. Alveolar-arterial oxygen tension gradients in cirrhosis of the liver. Am Heart J 1966;71:734-40.
18. Mellemgaard K, Winkler K, Tygstrup N, Georg J. Sources of veno-arterial admixture in portal hypertension. J Clin Invest 1963;42:1399-405.
19. Wilson RH, Ebert RV, Borden CW, Pearson RT, Johnson RS, Falk A, et al. The determinations of blood flow through non ventilated portions of the normal and diseased lung. Am Rev Tuberc 1953;68:177-87.
20. 85. J Clin Invest 1960;39: 1841-50.
21. Cotes JE, Field GB, Brown GJA, Read AE. Impairment of lung function after portocaval anastomosis. Lancet 1968;I:952-5.
22. Calabresi P, Abelman WH. Porto-caval and porto-pulmonary anastomosis in Laennec's cirrhosis and in heart failure. J Clin Invest 1957;36:1257-65.
23. 85). N Engl J Med 1961;265:410-4.
24. Nakamura T, Nakamura S, Tazoura T, Abe S, Aikawa T, Tokira K. Measurement of blood flow through porto-pulmonary anastomosis in portal hypertension. J Lab Clin Med 1965;65: 114-21.
25. Ruff F, Hughes JMB, Stanley N, McCarthy D, Geen R, Aronoff A, et al. Regional lung function in patients with hepatic cirrhosis. J Clin Invest 1971;50:2403-13.
26. Daoud FS, Reeves JT, Schaefer JW. Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. J Clin Invest 1972;51:1076-80.
27. Rodriguez-Roisin R, Roca J, Agusti AGN, Mastai R, Wagner PD, Bosch J. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 1987;135: 1085-92.
28. Mélot C, Naeije R, Dechamps P, Hallemans R, Lejeune P. Pulmonary and extrapulmonary contributors to hypoxemia in liver cirrhosis. Am Rev Respir Dis 1989;139:632-40.
29. Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 1977;72:305-9.
30. Edell ES, Cortese DA, Krowka MJ, Rehder K. Severe hypoxemia and liver disease. Am Rev Respir Dis 1989;142:1631-5.
31. Castaing Y, Manier G. Hemodynamic disturbances and VA/Q matching in hypoxemic cirrhotic patients. Chest 1989;96:10649.
32. Fluckiger M. Vorkommen von trommelschlägelförmigen Fingerendphalangen ohne chronische Veränderungen an der Lungen oder am Herzen. Wien Med Wschr 1884;34:1457.
33. Rydell R, Hoffbaner FW. Multiple arterio-venous fistulas in juvenile cirrhosis. Am J Med 1956;21:450-60.
34. Hansoti RC, Shah NJ. Cirrhosis of liver simulating congenital cyanotic heart disease. Circulation 1966;33:71-7.
35. Berthelot P, Walker JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liver - lung spider naevi. N Engl J Med 1966;274:291-8.
36. Karlish AJ, Marshall R, Reid L, Sherlock S. Cyanosis with hepatic cirrhosis. A case with multiple arterio-venous shunting. Thorax 1967;22:555-61.
37. Stanley NN, Woodgate DJ. Mottled chest radiograph and gas transfer defect in chronic liver disease. Thorax 1972;27:315-22.
38. Robin ED, Laman D, Horn BR, Theodore J. Platypnea related to orthodeoxia caused by true vascular shunts. N Engl J Med 1976;294:941-3.
39. Davis HH, Schwarz DJ, Lefrak SS, Susman N, Schainker BA. Alveolar capillary oxygen desequilibrium in hepatic cirrhosis. Chest 1978;73:507-11.
40. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Current concepts in diagnosis and therapeutic considerations. Chest 1994;105:1528-37.
41. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995;122:521-9.
42. Rodriguez-Roisin R Agusti A, Roca J. The hepatopulmonary syndrome: new names, old complexities; Thorax 1992;47:897-902.
43. Nerve P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998;11:1153-66.
44. Thorens JB, Junod AF. Hypoxaemia and liver cirrhosis: a new argumentin favour of a "diffusion-perfusion defect". Eur Respir J 1992;5:754-6.
45. Schenk P, Fuhrman V, Madl C, Funk G, Lehr S, Kandel O, et al. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002;51:853-9.
46. Martinez GP, Barbera JA, Visa J, Rimola A, Pare JC, Roca J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001;34:651-7.
47. Krowka MJ, Tajik JA, Dickson RE, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest 1990;97:1165-70.
48. Chang SW, Ohara N. Pulmonary circulatory dysfunction in rats with biliary cirrhosis: an animal model of the hepatopulmonary syndrome. Am Rev Respir Dis 1992;145:796-805.
49. Nunes H, Lebrec D, Mazmanian M, Capron F, Heller J, Tazi KA, et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001;164:879-85.
50. Rolla G, Brussino L, Colagrande P, Dutto L, Polizzi S, Scappaticci E, et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997;26:842-7.
51. Srivastava D, Preminger T, Lock JE, Mandell V, Keane JF, Mayer JE Jr, et al. Hepatic venous blood and the development of pulmonary arterio-venous malformations in congenital heart disease. Circulation 1995;92:1217-22.
52. Shah MJ, Rychick J, Fogel MA, Murphy JD, Jacobs ML. Pulmonary arterio-venous malformations after superior cavopulmonary connection: resolution after inclusion of hepatic veins in the pulmonary circulation. Ann Thorac Surg 1997;63:960-3.
53. Mantz FA, Craige E. Portal axis thrombosis with spontaneous porto-caval shunt and resultant cor pulmonale. Arch Pathol 1951;52:91-7.
54. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997;33:111-7.
55. Fishman AP. Clinical classification of pulmonary hypertension. Clin Chest Med 2001;22:385-91.
56. Naeije R. Pulmonary circulation. In: Respiratory Medicine. Third edition. Edited by CJ Gibson, DM Geddes, U Costabel, PJ Sterk, B Corris. Saunders, London, 2003, vol I, chap 2.6, pp 147-157.
57. Krowka MJ. Hepatopulmonary syndromes. Gut 2000;46:1-4.
58. Kuo PC, Johnson LB, Plotkin JS, Howell CD, Bartlett ST, Rubin LJ. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997;63:604-6.
59. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000;6:443-50.